N-Of-One Teams With The Personalized Medicine Coalition (PMC) To Support Physician Education On The Complexities Of Interpreting NGS Panels In Oncology

LEXINGTON, Mass.--(BUSINESS WIRE)--N-of-One, Inc., the leader in clinical interpretation for precision medicine in oncology, today announced that N-of-One has contributed its first article Empowering Physicians to Deliver Precision Medicine: The Role of Clinical Interpretation, to the PMC’s Education and Advocacy blog. The Personalized Medicine Coalition has invited N-of-One to join other PMC members in an effort to educate physicians on how precision medicine provides them with important understanding and insights regarding their patients’ diseases and their selection of therapeutic strategies for their patients.

A central theme of this initiative is educating physicians on the practical, real-world integration of molecular testing into patient care. This first article, written by N-of-One CMO Dr. Jennifer Levin Carter, helps educate physicians on how precision medicine can provide more effective therapeutic options for cancer patients. In addition, N-of-One CEO Chris Cournoyer will be speaking on a panel titled “Innovators in Personalized Medicine” at the Personalized Medicine Conference on November 19, 2015 in Boston, MA.

N-of-One supports the PMC’s efforts to help educate physicians on the value of next generation sequencing and other molecular diagnostics tests. Patient-specific, physician-ready clinical interpretation and clinical trial matching based on high quality clinical interpretation are two key capabilities that inform physicians in making therapeutic strategy decisions for their patients.

N-of-One clinical interpretation delivers the relevant scientific and clinical evidence and multi-variant analysis of the mutation profile of each patient’s tumor. This analysis links the clinical and scientific evidence of each patient’s unique molecular data from NGS and other molecular tests to the possible therapeutic strategies, including clinical trials, relevant for each patient.

About N-of-One

N-of-One, a leader in enabling precision medicine for oncology, leverages its world-class team of experts coupled with a highly proprietary platform that allows us to provide clinical solutions and services, such as molecular interpretation, to clinicians at the point of care. N-of-One’s team of experts has interpreted thousands of samples for oncologists and patients worldwide, through partnerships with leading diagnostic companies, hospital systems, directly to oncologists and through employee access benefit programs. N-of-One does not provide medical advice or promote any product or service. For more information, please visit www.n-of-one.com or call 617-202-9808.